Dr. Geertrui Tavernier graduated as master in pharmaceutical sciences in June, 2008 (University of Ghent, Belgium). She performed her doctoral studies at the University of Ghent (Belgium) and Max Planck Institute for Molecular Genetics (Berlin, Germany) and obtained her PhD degree in December, 2012. Her PhD dissertation focused on mRNA as a gene therapeutic, cellular delivery of nanomedicines, the immunogenic properties of delivery vehicles and their cargo and the reprogramming of fibroblasts towards pluripotency. This interdisciplinary background allows for broad coverage of many aspects of life sciences. Collaboration with other PhD promoted scientists guarantees Medocu´s manuscripts to be of the highest scientific standards. Specific training courses (a.o. English writing skills) and our writing experience ensure the use of fluent and correct academic English language. Because of our efficiency and flexibility, Medocu quickly meets your textural wishes.
References
Complete preparation and/or language/editorial support of both experimental and review articles for private clients & Mediwriter www.mediwriter.de (collaboration ongoing)
Medical Writing Services for www.novellashealthcare.eu (2016)
Medical Writing (CSR, IB, SOP, CDP, etc.) for Mithra Pharmaceuticals (2016)
Website copywriting for Dr. Jaglas (2015)
Scientific product information for medical professionals as well as corporate documents for registration purposes, and, website copywriting, for Primrose Laboratories (2013 and ongoing)
Current methods for inducing pluripotency in somatic cells, Advanced Materials (2013)
The cytotoxic and immunogenic hurdles associated with non-vial mRNA-mediated reprogramming of human fibroblasts, Biomaterials (2012)
Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc, Biomaterials (2012)
mRNA as gene therapeutic: how to control protein expression, Journal of Controlled Release (2011)
mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers, Journal of Controlled Release (2010)